Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Oracle: Court Rules Rimini Street Infringe Oracle Copyrights - Quick Facts

RELATED NEWS
Trade ORCL now with 

Oracle Corp. (ORCL: Quote) said the Court ruled that Rimini Street infringed Oracle copyrights by installing PeopleSoft software on Rimini Street's computer systems in order to develop and test software updates for Rimini Street's customers. The Court rejected Rimini Street's defense that the copying was permitted by licenses held by Rimini Street's customers, the City of Flint and Pittsburgh Public Schools. Also, it rejected Rimini Street's defense that Oracle had granted Rimini Street an implied license and ordered that partial judgment be entered in Oracle's favor.

On February 13, 2014, the U.S. District Court in Las Vegas entered an order granting in part Oracle's motion for summary judgment in its case against Rimini Street, Inc. and its Chief Executive, Seth Ravin.

Oracle attorney, David Boies, noted, "As the Court's ruling explains, Rimini Street has used illegal and unlicensed copies of PeopleSoft software as the basis of its business. We look forward to holding Rimini Street and Seth Ravin accountable at trial for the damages caused by their misconduct." The Court reserved for trial issues on certain other software and customers, and a second motion by Oracle for summary judgment on other issues remains pending.

Register
To receive FREE breaking news email alerts for Oracle Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Micro-blogging site Twitter Inc said Tuesday after the markets closed that its second quarter loss widened from last year, hurt mainly by stock-based compensation expense, even as revenue more than doubled thanks to growth in advertising. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Pharmaceutical giant Pfizer, Inc., which was aspiring to buy British drug maker AstraZeneca Plc, reported Tuesday a profit for the second quarter that plunged 79 percent from last year, which reflected hefty gains from animal health business sales. Total revenues declined 2 percent, as it continued to be hurt by generic competition for major drugs. Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.